@article{9c9e0203db774b85a32023febc1ff032,
title = "The Role of Checkpoint Inhibitors in Glioblastoma.",
author = "Kunal Desai and Anne Hubben and Manmeet Ahluwalia",
note = "Given its poor prognosis, glioblastoma represents an area of high unmet clinical need. Standard of care for the treatment of glioblastoma in the frontline setting is limited to surgical resection, radiation, and temozolomide, with the more recent addition of Tumor Treating Fields. Several agents, including bevacizumab, lomustine, and carmustine have been approved in the recurrent setting.",
year = "2019",
month = aug,
day = "1",
doi = "10.1007/S11523-019-00655-3",
language = "American English",
volume = "14",
journal = "Targeted Oncology",
}